LR
Louise Rodino-Klapac
DELAYED 1 MONTH
President, R&D and Tech Ops
Sarepta Therapeutics, Inc.
Filings
3
Companies
1
Latest
Mar 11, 2026
Transactions
Signal
Ticker / Company
Insider
Transaction
Value
Filed
—
Sarepta Therapeutics, Inc.
Louise Rodino-Klapac
President, R&D and Tech Ops
Option Exercise
—
8,125 sh
Mar 4 1:02 AM
Mar 1, 2026